• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病性新生血管性青光眼的黄斑水肿及其与全身性疾病的关联

Macular Edema in Diabetic Neovascular Glaucoma and Its Association with Systemic Diseases.

作者信息

Kang Kyumin, Kang Kyung Tae, Kim Yu Cheol

机构信息

Department of Ophthalmology, Keimyung University School of Medicine, Keimyung University Dongsan Hospital,Daegu, Korea.

出版信息

Korean J Ophthalmol. 2025 Aug;39(4):330-338. doi: 10.3341/kjo.2024.0122. Epub 2025 Jun 30.

DOI:10.3341/kjo.2024.0122
PMID:40583202
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12358730/
Abstract

PURPOSE

This study assessed the development of macular edema (ME) and its association with systemic diseases in patients with diabetic neovascular glaucoma (NVG).

METHODS

The medical records of 40 patients (45 eyes) diagnosed with diabetic NVG, between January 2017 and April 2022, were retrospectively reviewed. At the time of NVG diagnosis, central retinal thickness (CRT) was measured using optical coherence tomography. The eyes were categorized into groups with ME (CRT ≥300 μm) and without ME. Systemic diseases, ocular parameters, and prior treatments such as panretinal photocoagulation and intravitreal anti-vascular endothelial growth factor injections were compared between the two groups.

RESULTS

Only 6 of the 45 eyes (13.3%) had ME at the time of NVG diagnosis. No significant differences were observed between the ME and non-ME groups in terms of systemic diseases, including hypertension, hyperlipidemia, ischemic heart disease, cerebrovascular accident, and chronic kidney disease. Other clinical characteristics, such as age, sex, body mass index, smoking history, best-corrected visual acuity, intraocular pressure, lens status, and history of ocular treatment, were also comparable between groups.

CONCLUSIONS

In patients with diabetic NVG, ME was observed in a minority of cases and showed no significant association with systemic diseases.

摘要

目的

本研究评估了糖尿病性新生血管性青光眼(NVG)患者黄斑水肿(ME)的发生情况及其与全身性疾病的关联。

方法

回顾性分析2017年1月至2022年4月期间诊断为糖尿病性NVG的40例患者(45只眼)的病历。在NVG诊断时,使用光学相干断层扫描测量中央视网膜厚度(CRT)。将这些眼分为有ME(CRT≥300μm)和无ME两组。比较两组之间的全身性疾病、眼部参数以及先前的治疗,如全视网膜光凝和玻璃体内抗血管内皮生长因子注射。

结果

45只眼中只有6只(13.3%)在NVG诊断时存在ME。在全身性疾病方面,包括高血压、高脂血症、缺血性心脏病、脑血管意外和慢性肾脏病,ME组和非ME组之间未观察到显著差异。其他临床特征,如年龄、性别、体重指数、吸烟史、最佳矫正视力、眼压、晶状体状态和眼部治疗史,两组之间也具有可比性。

结论

在糖尿病性NVG患者中,ME仅在少数病例中观察到,且与全身性疾病无显著关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1662/12358730/b4a51e924e57/kjo-2024-0122f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1662/12358730/b4a51e924e57/kjo-2024-0122f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1662/12358730/b4a51e924e57/kjo-2024-0122f1.jpg

相似文献

1
Macular Edema in Diabetic Neovascular Glaucoma and Its Association with Systemic Diseases.糖尿病性新生血管性青光眼的黄斑水肿及其与全身性疾病的关联
Korean J Ophthalmol. 2025 Aug;39(4):330-338. doi: 10.3341/kjo.2024.0122. Epub 2025 Jun 30.
2
Assessing the Role of Statins as an Adjunctive Anti-VEGF Therapy for Clinically Significant Macular Edema (CSME) in Type 2 Diabetes Mellitus.评估他汀类药物作为2型糖尿病患者临床显著性黄斑水肿(CSME)辅助抗血管内皮生长因子(VEGF)治疗的作用。
Rom J Ophthalmol. 2025 Apr-Jun;69(2):219-227. doi: 10.22336/rjo.2025.35.
3
Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.抗血管内皮生长因子联合玻璃体内注射类固醇治疗糖尿病性黄斑水肿。
Cochrane Database Syst Rev. 2018 Apr 18;4(4):CD011599. doi: 10.1002/14651858.CD011599.pub2.
4
Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy.光学相干断层扫描(OCT)用于检测糖尿病视网膜病变患者的黄斑水肿。
Cochrane Database Syst Rev. 2015 Jan 7;1(1):CD008081. doi: 10.1002/14651858.CD008081.pub3.
5
Impact of diabetes and diabetic retinopathy on neovascular exudative age-related macular degeneration.糖尿病及糖尿病视网膜病变对新生血管性渗出性年龄相关性黄斑变性的影响。
Acta Ophthalmol. 2025 Sep;103(6):e374-e384. doi: 10.1111/aos.17502. Epub 2025 Apr 17.
6
Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy.光学相干断层扫描(OCT)用于检测糖尿病视网膜病变患者的黄斑水肿。
Cochrane Database Syst Rev. 2011 Jul 6(7):CD008081. doi: 10.1002/14651858.CD008081.pub2.
7
Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.抗血管内皮生长因子治疗糖尿病性黄斑水肿:一项网状Meta分析。
Cochrane Database Syst Rev. 2017 Jun 22;6(6):CD007419. doi: 10.1002/14651858.CD007419.pub5.
8
Real-world clinical insights and aqueous humor biomarker analysis of diabetic macular edema subtypes classified by OCT following intravitreal injections.玻璃体内注射后,根据光学相干断层扫描(OCT)分类的糖尿病性黄斑水肿亚型的真实世界临床见解及房水生物标志物分析
BMC Ophthalmol. 2025 Jul 1;25(1):374. doi: 10.1186/s12886-025-04186-6.
9
Anti-vascular endothelial growth factor for neovascular glaucoma.抗血管内皮生长因子治疗新生血管性青光眼。
Cochrane Database Syst Rev. 2023 Apr 3;4(4):CD007920. doi: 10.1002/14651858.CD007920.pub4.
10
Comparable choroidal thickness between treated eyes and untreated fellow-eyes in patients with unilateral neovascular AMD: a paired-eyes comparative study.单侧新生血管性年龄相关性黄斑变性患者治疗眼与未治疗对侧眼脉络膜厚度的比较:配对眼比较研究。
Graefes Arch Clin Exp Ophthalmol. 2025 Mar 8. doi: 10.1007/s00417-025-06751-7.

本文引用的文献

1
Structural and Vascular Features of Macula Related to the Recurrence of Macular Edema in Central Retinal Vein Occlusion After Anti-VEGF Therapy.与抗VEGF治疗后视网膜中央静脉阻塞黄斑水肿复发相关的黄斑结构和血管特征
J Ophthalmol. 2025 Feb 28;2025:8824342. doi: 10.1155/joph/8824342. eCollection 2025.
2
Sodium-glucose co-transporter 2 inhibitor add-on therapy for metformin delays diabetic retinopathy progression in diabetes patients: a population-based cohort study.钠-葡萄糖共转运蛋白 2 抑制剂联合二甲双胍治疗可延缓糖尿病患者糖尿病视网膜病变的进展:一项基于人群的队列研究。
Sci Rep. 2023 Oct 10;13(1):17049. doi: 10.1038/s41598-023-43893-2.
3
A Review of Neovascular Glaucoma: Etiology, Pathogenesis, Diagnosis, and Treatment.
新生血管性青光眼:病因、发病机制、诊断与治疗的综述。
Medicina (Kaunas). 2022 Dec 18;58(12):1870. doi: 10.3390/medicina58121870.
4
Diabetic Macular Edema: Current Understanding, Molecular Mechanisms and Therapeutic Implications.糖尿病性黄斑水肿:当前认识、分子机制及治疗意义。
Cells. 2022 Oct 25;11(21):3362. doi: 10.3390/cells11213362.
5
Anti-VEGF Drugs Dynamics: Relevance for Clinical Practice.抗血管内皮生长因子药物动力学:与临床实践的相关性
Pharmaceutics. 2022 Jan 23;14(2):265. doi: 10.3390/pharmaceutics14020265.
6
Central retinal thickness changes and risk of neovascular glaucoma after intravitreal bevacizumab injection in patients with central retinal vein occlusion.中心性视网膜静脉阻塞患者玻璃体内注射贝伐单抗后视网膜中央厚度的变化与新生血管性青光眼的风险。
Sci Rep. 2022 Feb 8;12(1):2051. doi: 10.1038/s41598-022-06121-x.
7
Ischemic index and distribution of retinal capillary non-perfusion in neovascular glaucoma.缺血指数与新生血管性青光眼视网膜毛细血管无灌注的分布。
Front Biosci (Landmark Ed). 2022 Jan 17;27(1):24. doi: 10.31083/j.fbl2701024.
8
Involvement of Cytokines in the Pathogenesis of Diabetic Macular Edema.细胞因子在糖尿病性黄斑水肿发病机制中的作用。
Int J Mol Sci. 2021 Mar 26;22(7):3427. doi: 10.3390/ijms22073427.
9
Two-year outcomes of the treat-and-extend regimen using aflibercept for treating diabetic macular oedema.经玻璃体腔内注射阿柏西普治疗糖尿病黄斑水肿的治疗-随访方案的两年疗效。
Sci Rep. 2020 Dec 16;10(1):22030. doi: 10.1038/s41598-020-78954-3.
10
Relationships among Retinal Nonperfusion, Neovascularization, and Vascular Endothelial Growth Factor Levels in Quiescent Proliferative Diabetic Retinopathy.静止期增殖性糖尿病视网膜病变中视网膜无灌注、新生血管形成与血管内皮生长因子水平之间的关系
J Clin Med. 2020 May 13;9(5):1462. doi: 10.3390/jcm9051462.